| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.19 | 0.0006 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.0006 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0008 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |